Nanoparticle cancer vaccines: Design considerations and recent advances
Vaccines therapeutics manipulate host's immune system and have broad potential for cancer prevention and treatment. However, due to poor immunogenicity and limited safety, fewer cancer vaccines have been successful in clinical trials. Over the past decades, nanotechnology has been exploited to...
Main Authors: | Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao, Guihua Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S181808761930128X |
Similar Items
-
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
by: K. Swetha, et al.
Published: (2023-03-01) -
mRNA cancer vaccines: Advances, trends and challenges
by: Qing He, et al.
Published: (2022-07-01) -
Tailored Nanoparticles as Vaccine Components
by: Alina Popa, et al.
Published: (2021-12-01) -
Recent progress in mRNA cancer vaccines
by: Ruhui Yao, et al.
Published: (2024-12-01) -
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
by: Yuan Yuan, et al.
Published: (2023-01-01)